openPR Logo
Press release

PD-L1 Biomarker Testing Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

09-15-2023 01:58 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

PD-L1 Biomarker Testing Market Revenue, Insights, Overview,

PD-L1 Biomarker Testing Market

The global PD-L1 Biomarker Testing market was valued at US$ 2088 million in 2022 and is anticipated to reach US$ 14870 million by 2029, witnessing a CAGR of 38.7% during the forecast period 2023-2029.

Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6F9402/Global_PD_L1_Biomarker_Testing_Market_Size_Status_and_Forecast_2022

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.

Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).

PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti-PD-1/PD-L1 therapies.

PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.

PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.

North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.

By Type
• PD-L1 (22C3)
• PD-L1(28-8)
• PD-L1 (SP142)
• PD-L1 (SP263)
By Application
• Hospital
• Diagnostic Center

Key Players
Agilent Technologies, Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-6F9402/global-pd-l1-biomarker-testing

Similar Reports:

1. https://reports.valuates.com/market-reports/QYRE-Auto-13G6162/global-metabolic-biomarker-testing

2. https://reports.valuates.com/market-reports/QYRE-Auto-3N6385/global-genomics-biomarkers

3. https://reports.valuates.com/market-reports/QYRE-Auto-33J8028/global-non-alcoholic-steatohepatitis-nash-biomarkers

4. https://reports.valuates.com/market-reports/QYRE-Auto-26T14297/global-biomarker-technology

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PD-L1 Biomarker Testing Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports here

News-ID: 3210059 • Views:

More Releases from Valuates Reports

AI-powered ESG Reporting Software Market Revenue Share, Insights & Future Outloo …
AI-powered ESG Reporting Software Market Size The global market for AI-powered ESG Reporting Software was valued at US$ 841 million in the year 2024 and is projected to reach a revised size of US$ 2524 million by 2031, growing at a CAGR of 17.0% during the forecast period. North American market for AI-powered ESG Reporting Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at
Electric & Hydraulic Wellhead Drives for Onshore Market Revenue Share, Insights …
Electric & Hydraulic Wellhead Drives for Onshore Market The global market for Electric & Hydraulic Wellhead Drives for Onshore was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. A wellhead is the component at the surface of an oil or gas well that provides the structural and pressure-containing interface for
All Flash Network Attached Storage (NAS) Market Revenue Share, Insights & Future …
All Flash Network Attached Storage (NAS) Market The global market for All Flash Network Attached Storage (NAS) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Network additional storage is the name of a specialized data storage technology that can be directly connected to the computer network, providing centralized data
Portable Normal Pressure Fire Fighting Pump for Industrial Market Revenue Share, …
Portable Normal Pressure Fire Fighting Pump for Industrial Market Size The global market for Portable Normal Pressure Fire Fighting Pump for Industrial was valued at US$ 132 million in the year 2024 and is projected to reach a revised size of US$ 186 million by 2031, growing at a CAGR of 5.1% during the forecast period. Download Free Data: https://reports.valuates.com/request/sample/QYRE-Auto-34T15717/Global_Portable_Normal_Pressure_Fire_Fighting_Pump_for_Industrial_Market_Research_Report_2023?utm_source=Openpr&utm_medium=Referral Report Scope This report aims to provide a comprehensive presentation of the global market

All 5 Releases


More Releases for Biomarker

Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Multiplex Biomarker Imaging Market Size By 2025? In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic,
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints), Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference: Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being. CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558 This latest report researches the industry structure,